Skip to content

Study · Observational study · n = 58 · 2015

3 results

Histrelin for central precocious puberty-a single surgeon experience.

Rosati S, Maarouf R, Brown K, Poppe M, Parrish D, Haynes J, Lanning D

The Journal of surgical research30 Mar 2015Cited by 10 (Europe PMC)

PMID25899147 (opens in a new tab)DOI10.1016/j.jss.2015.03.071 (opens in a new tab)PepBankPUB-25899147
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanObservational studySafety outcome

    In children with central precocious puberty, histrelin implants were placed, replaced, or removed without significant difficulty.

    In plain wordsIn children, histrelin implant procedures occurred without significant difficulty.

    Peptide
    Histrelin
    Outcome
    Not applicableImplant procedure difficulty
    Study

    n = 58

    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    All implants were placed, replaced, or removed without significant difficulty, and there were no complications.
    2 context sentences
    Summary · context
    The aim of this study was to conduct a retrospective review of one surgeon's experience with the histrelin implant and to examine patient satisfaction.
    Summary · context
    Fifty-eight children, average age 8.4 y old (range 7-14), underwent at least one histrelin implant insertion for treatment of CPP.
  2. 02HumanObservational studySafety outcome

    In children with central precocious puberty undergoing histrelin implant procedures, no complications occurred.

    In plain wordsIn children undergoing histrelin implant procedures, no complications occurred.

    Peptide
    Histrelin
    Outcome
    Not applicableComplications
    Study

    n = 58

    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    All implants were placed, replaced, or removed without significant difficulty, and there were no complications.
    2 context sentences
    Summary · context
    The aim of this study was to conduct a retrospective review of one surgeon's experience with the histrelin implant and to examine patient satisfaction.
    Summary · context
    Fifty-eight children, average age 8.4 y old (range 7-14), underwent at least one histrelin implant insertion for treatment of CPP.
  3. 03HumanObservational studyOther

    Parents of 44 children with central precocious puberty rated histrelin implant treatment highly.

    In plain wordsParents of 44 children rated histrelin implant treatment highly.

    Peptide
    Histrelin
    Outcome
    Not applicableParent satisfaction
    Study

    n = 44

    Outcome group
    Patient-reported outcomes · Whole body
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    Parents of 44 patients were able to be reached by telephone for this study and rated the histrelin implant treatment highly.
    2 context sentences
    Summary · context
    The aim of this study was to conduct a retrospective review of one surgeon's experience with the histrelin implant and to examine patient satisfaction.
    Summary · context
    Fifty-eight children, average age 8.4 y old (range 7-14), underwent at least one histrelin implant insertion for treatment of CPP.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.